Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Monooxygenase DBH-like 1
Introduction
DBH-like monooxygenase protein 1, also known as monooxygenase X, is an enzyme that in humans is encoded by the MOXD1 gene.[1][2]
DBH-like 1 maintains many of the structural features of dopamine beta-monooxygenase DBH.[3] Since Peptidylglycine alpha-hydroxylating monooxygenase (PHM; EC 1.14.17.3) is homologous to dopamine beta-monooxygenase (DBM; EC 1.14.17.1)[4] this concerns a structural basis for a new family of copper type II, significantly specific for ascorbate-dependent monooxygenases[4] based on the corresponding mouse homolog.[2] The pathway of catecholamine synthesis is a possible catecholamine-binding metabolic copper[5] enzyme domain, a neuron-like property encoding MOX without a signal sequence enzyme metabolism resolving the monooxygenase X chemical pathway[5] of an unknown substrate,[2] exogenous MOX is not secreted, and it localizes throughout the endoplasmic reticulum,[5] in both endocrine or nonendocrine cells.[5]
Deficiency
Deficiency
DBH deficiency has been treated effectively with L-threo-3,4-dihydroxyphenylserine (DOPS).[6]
See also
See also
References
References
- ↑ “Entrez Gene: monooxygenase, DBH-like 1”.
- ↑ 2.0 2.1 2.2 Chambers KJ, Tonkin LA, Chang E, Shelton DN, Linskens MH, Funk WD (September 1998). “Identification and cloning of a sequence homologue of dopamine beta-hydroxylase”. Gene. 218 (1–2): 111–20. doi:10.1016/S0378-1119(98)00344-8. PMID 9751809.
- ↑ Prigge ST, Mains RE, Eipper BA, Amzel LM (August 2000). “New insights into copper monooxygenases and peptide amidation: structure, mechanism and function”. Cell Mol Life Sci. 57 (8–9): 1236–59. doi:10.1007/PL00000763. ISSN 1420-682X. PMID 11028916.
- ↑ 4.0 4.1 Southan C, Kruse LI (September 1989). “Sequence similarity between dopamine beta-hydroxylase and peptide alpha-amidating enzyme: evidence for a conserved catalytic domain”. FEBS Lett. 255 (1): 116–20. doi:10.1016/0014-5793(89)81072-5. PMID 2792366.
- ↑ 5.0 5.1 5.2 5.3 Xin X, Mains RE, Eipper BA (November 2004). “Monooxygenase X, a member of the copper-dependent monooxygenase family localized to the endoplasmic reticulum”. J. Biol. Chem. 279 (46): 48159–67. doi:10.1074/jbc.M407486200. PMID 15337741.
- ↑ Vincent S, Robertson D (May 2002). “The broader view: catecholamine abnormalities”. Clin Auton Res. Suppl. 1: 144–9. ISSN 0959-9851. PMID 12102462.
Further reading
Further reading
- Clark HF, Gurney AL, Abaya E, et al. (2003). “The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment”. Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
- Xin X, Mains RE, Eipper BA (2004). “Monooxygenase X, a member of the copper-dependent monooxygenase family localized to the endoplasmic reticulum”. J. Biol. Chem. 279 (46): 48159–67. doi:10.1074/jbc.M407486200. PMID 15337741.
- Bon S, Lamouroux A, Vigny A, Massoulié J, Mallet J, Henry JP (October 1991). “Amphiphilic and nonamphiphilic forms of bovine and human dopamine beta-hydroxylase”. J. Neurochem. 57 (4): 1100–11. doi:10.1111/j.1471-4159.1991.tb08267.x. ISSN 0022-3042. PMID 1654385.